Promore Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Erik Magnusson, was filed 01 Dec 2021.
Promore Pharma AB: what insiders have been doing
This page follows insider dealings at Promore Pharma AB as filed with Finansinspektionen. Nothing new has been filed by managers of Promore Pharma AB in twelve months, the latest record being from 1 December 2021.
Over the whole record (from 2021), the tally stands at 4 purchases and no sales.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Financial data
· cache
- 39,800 shares@ SEK 1.578764.3% of flowAktieISIN SE0009947740FI:csv-b013bf3e0d6d63d96e63Canonical exit: 1 Mar 2022 (T+90)
- 10,000 shares@ SEK 2.0037.6% of flowBTA (betald tecknad aktie)ISIN SE0016074629FI:csv-1552a89045c0fa2b86e5Canonical exit: 27 Sept 2021 (T+90)
- 9,084,292 shares@ SEK 2.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0016074629FI:csv-2bec0a0171e0039273e5
- 66,666 shares@ SEK 2.0018.7% of flowBTA (betald tecknad aktie)ISIN SE0016074629FI:csv-2d1534625e5b6348c893
- 289,344 shares@ SEK 2.0081.3% of flowBTA (betald tecknad aktie)ISIN SE0016074629FI:csv-ae463f951687d6342467
- 16,666 shares@ SEK 2.0062.4% of flowBTA (betald tecknad aktie)ISIN SE0009947740FI:csv-096bc8e4b50d71b504fbCanonical exit: 15 Sept 2021 (T+90)
- 17,272 shares@ SEK 2.0035.7% of flowBTA (betald tecknad aktie)FI:csv-7f3a61d9585a826611b5
- 244,019 shares0Teckningsrätt/UniträttISIN SE0016074611FI:csv-f97ade195a2dcb048a55Canonical exit: 1 Sept 2021 (T+90)
8 of 8 declarations
About Promore Pharma AB
Promore Pharma AB is a Swedish biopharmaceutical company focused on developing treatments for wounds and scars. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations